Nxera Pharma Co (FRA:JSS) Cyclically Adjusted Book per Share: €3.69 (As of Mar. 2026)


FRA:JSS Nxera Pharma Co Ltd FRA:JSS
73 GF Score
Price €5.10
GF Value €6.99
! 7 Warning Signs
View Full Analysis

What is Nxera Pharma Co Cyclically Adjusted Book per Share?

Nxera Pharma Co FRA:JSS -0.97% 73 Cyclically Adjusted Book per Share is €3.69 as of Mar. 2026. GuruFocus rates FRA:JSS with a GF Score™ of 73/100 and a GF Value™ of €6.99. The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Nxera Pharma Co's adjusted book value per share for the three months ended in Mar. 2026 was €3.836. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €3.69 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Nxera Pharma Co's average Cyclically Adjusted Book Growth Rate was 6.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 11.10% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 13.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Nxera Pharma Co was 15.20% per year. The lowest was 11.10% per year. And the median was 14.20% per year.

As of today (2026-07-03), Nxera Pharma Co's current stock price is €5.10. Nxera Pharma Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €3.69. Nxera Pharma Co's Cyclically Adjusted PB Ratio of today is 1.38.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Nxera Pharma Co was 11.09. The lowest was 1.11. And the median was 3.93.


Nxera Pharma Co  (FRA:JSS) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Nxera Pharma Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=5.10/3.69
=1.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Nxera Pharma Co was 11.09. The lowest was 1.11. And the median was 3.93.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Nxera Pharma Co Cyclically Adjusted Book per Share Related Terms


Nxera Pharma Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Nxera Pharma Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nxera Pharma Co Cyclically Adjusted Book per Share Chart

Nxera Pharma Co Annual Data
Trend Mar16 Mar17 Mar18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.20 3.45 3.57 3.80 3.64

Nxera Pharma Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.96 3.86 3.81 3.64 3.69

FRA:JSS vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Nxera Pharma Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nxera Pharma Co Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nxera Pharma Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Nxera Pharma Co's Cyclically Adjusted PB Ratio falls into.


FRA:JSS
73GF Score
Nxera Pharma Co Ltd FRA:JSS
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nxera Pharma Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Nxera Pharma Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=3.836/112.7000*112.7000
=3.836

Current CPI (Mar. 2026) = 112.7000.

Nxera Pharma Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 3.656 98.100 4.200
201609 3.539 98.000 4.070
201612 3.675 98.400 4.209
201703 3.470 98.100 3.986
201706 3.605 98.500 4.125
201709 3.467 98.800 3.955
201712 4.972 99.400 5.637
201803 4.905 99.200 5.573
201806 4.741 99.200 5.386
201809 4.571 99.900 5.157
201812 4.269 99.700 4.826
201903 4.549 99.700 5.142
201906 4.441 99.800 5.015
201909 4.652 100.100 5.238
201912 4.824 100.500 5.410
202003 4.602 100.300 5.171
202006 4.373 99.900 4.933
202009 4.812 99.900 5.429
202012 5.147 99.300 5.842
202103 5.260 99.900 5.934
202106 5.164 99.500 5.849
202109 5.090 100.100 5.731
202112 5.481 100.100 6.171
202203 5.313 101.100 5.923
202206 4.859 101.800 5.379
202209 4.793 103.100 5.239
202212 4.948 104.100 5.357
202303 4.965 104.400 5.360
202306 4.969 105.200 5.323
202309 4.461 106.200 4.734
202312 4.757 106.800 5.020
202403 4.523 107.200 4.755
202406 4.515 108.200 4.703
202409 4.750 108.900 4.916
202412 4.732 110.700 4.817
202503 4.630 111.100 4.697
202506 4.367 111.700 4.406
202509 4.181 112.000 4.207
202512 3.692 113.000 3.682
202603 3.836 112.700 3.836

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €3.69 mean?
Nxera Pharma Co (FRA:JSS) has a Cyclically Adjusted Book per Share of €3.69 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Nxera Pharma Co and its competitors.
Is Nxera Pharma Co's Cyclically Adjusted Book per Share too high?
Nxera Pharma Co's current Cyclically Adjusted Book per Share is €3.69. Overall, Nxera Pharma Co has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.
How does Nxera Pharma Co's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Nxera Pharma Co's Cyclically Adjusted Book per Share of €3.69 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Nxera Pharma Co and its competitors. Nxera Pharma Co's current Cyclically Adjusted Book per Share is €3.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nxera Pharma Co stock overvalued right now?
Nxera Pharma Co (FRA:JSS) has a current Cyclically Adjusted Book per Share of €3.69. The stock's GF Value™ is €6.99, compared to a current price of €5.10 — trading 27% below its estimated fair value. The current Cyclically Adjusted Book per Share is €3.69. Nxera Pharma Co's overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Nxera Pharma Co (FRA:JSS), the current Cyclically Adjusted Book per Share is €3.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nxera Pharma Co (FRA:JSS) Overvalued in 2026?

Based on GuruFocus' analysis, Nxera Pharma Co stock appears to be undervalued. The current stock price of €5.10 is trading 27% below its estimated GF Value™ of €6.99.

Key valuation signals for FRA:JSS:

  • Cyclically Adjusted Book per Share: €3.69
  • GF Value™: €6.99 vs. price of €5.10 (27% below fair value)
  • GF Score™: 73/100 with 7 warning signs

No single metric tells the full story. See the FRA:JSS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nxera Pharma Co Business Description

Other Exchanges SOLTF:USA4565:Japan
Address Midtown East, 9-7-2 Akasaka Minato-ku, Tokyo, JPN, 107-0052
Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein Coupled Receptors (GPCRs).
73GF Score

Get the complete analysis for FRA:JSS

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.10
Price
€6.99
GF Value